Speakeasy Cannabis Club Appoints Brian Peery as President

Published: July 23, 2018

Speakeasy Cannabis Club Appoints Brian Peery as President

SpeakEasy Cannabis Club Ltd., a late stage ACMPR applicant, today announces the appointment of Brian Peery as President and Deborah Cotter as Corporate Secretary of the Company.

“It is with great pleasure that I take my next corporate step with SpeakEasy. I couldn’t ask for more in regards to such a dedicated, passionate and exciting group. We have the make up to become a leader, not just within Canada, but on a International scale,” stated Peery, “I look forward to being an integral part in the future success of SpeakEasy. Together we will work to preserve premium cannabis standards while accelerating the research and development of new cannabis strains that will help SpeakEasy become a leading producer of premium quality, small batch cannabis products.”

Prior to his appointment, Mr. Peery was a portfolio manager with Hennessy Funds of San Francisco, where he oversaw in excess of $3 billion in assets. Previously, Mr. Peery held positions as senior equities analyst and managed the research and trading divisions of both full-service and boutique investment firms. Mr. Peery has been a member of SpeakEasy’s Advisory Board since May, 2018 and is working towards relocating to Vancouver, BC. Marc Geen, CEO states, “I am extremely excited that Brian has agreed to join SpeakEasy on a full time basis as President of our fast growing company. Brian brings a wealth of knowledge to the corporate side as well as strategic relationships garnered from his many years as one of the most respected small cap fund managers in the US. We are striving to enhance our senior positions within SpeakEasy, and this addition will be significant for us moving forward.”

Alongside Mr. Peery joins Ms. Cotter who has served as Corporate Secretary for numerous publicly traded companies over the last 18 years including ID Biomedical Corporation, which was bought by Glaxo Smith Kline plc. ID Biomedical grew from an initial $3 million market capitalization to $1.7 billion at the time of its takeover offer from Glaxo Smith Kline plc.

In connection with their appointments, SpeakEasy has entered into employment agreements with each of Mr. Peery and Ms. Cotter pursuant to which each of them are entitled to receive, in addition to their salaries and in accordance with applicable laws (including the policies of the Canadian Securities Exchange (the “CSE”)), incentive stock options and performance bonuses, including bonuses payable by the issuance of common shares in the capital of SpeakEasy (the “Common Shares”).

The Company’s board of directors has approved the grant of up to an aggregate of 2,700,000 stock options (the “Options”), 2,3000,000 of the 2,700,000 option have been granted to four members of the Company’s senior management, including Mr. Peery and Ms. Cotter. 1,300,000 incentive stock options were granted with an exercise price of $0.70 and 1,000,000 incentive stock options were granted with an exercise price of $0.95. The options will expire 5 years from the date of the grant of options. The grant of Options will be made in compliance with applicable laws, including CSE policies.

Recent News

View All News Items

Latest Article

How Database Integrations Can Improve Every Step in Your Cannabis Supply Chain Labeling

How Database Integrations Can Improve Every Step in Your Cannabis Supply Chain Labeling

At any step in the cannabis supply chain, your labeling system should allow for full control and traceability, from seed to sale. Implementing lean principles and labeling best practices across the cannabis supply chain can help you streamline your seed-to-sale labeling process and help you gain control.

Click below to read the full blog and learn how to reduce waste, cut costs, and gain efficiency with cannabis labeling: https://bit.ly/2KwZ5IQ

Read Article